Choice and adherence in preventive treatment for tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 523s Year: 2003
Impact of pre-test voluntary counseling on notification of HIV-infection in patients with tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 650s Year: 2005
The effect of education on adherence to tuberculosis therapy Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004
Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion Source: Eur Respir J 2004; 24: Suppl. 48, 463s Year: 2004
Patient choice promotes adherence in preventive treatment for latent tuberculosis Source: Eur Respir J 2007; 30: 728-735 Year: 2007
Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006
Effectiveness of a personalized smoking cessation counseling program in patients with oral cancer: preliminary results Source: International Congress 2017 – Smoking cessation Year: 2017
Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children Source: Eur Respir J, 57 (1) 2001756; 10.1183/13993003.01756-2020 Year: 2021
Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review Source: Eur Respir J, 53 (1) 1801030; 10.1183/13993003.01030-2018 Year: 2019
An intervention to modify patients‘ beliefs about maintenance therapy and improve adherence to medication Source: Eur Respir J 2005; 26: Suppl. 49, 46s Year: 2005
Experience of isofon use for therapy and chemoprophylaxis of tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 486s Year: 2004
Barriers and facilitators of a latent tuberculosis screening and treatment programme of recent migrants Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020
Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study Source: Eur Respir J 2001; 18: 369-375 Year: 2001
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Intervention study to evaluate effectiveness of integrated therapy (varenicline plus montivational interviewing) for smoking cessation in diabetic patients: Source: Annual Congress 2012 - Smoking tobacco: from second hand to earthquake Year: 2012
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015
Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006